Cell Fusion in Human Cancer: The Dark Matter Hypothesis

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2019 Feb 10

PMID 30736482

Citations 34

Authors

Julian Weiler

Thomas Dittmar

Affiliations

Soon will be listed here.

Abstract

Current strategies to determine tumor × normal (TN)-hybrid cells among human cancer cells include the detection of hematopoietic markers and other mesodermal markers on tumor cells or the presence of donor DNA in cancer samples from patients who had previously received an allogenic bone marrow transplant. By doing so, several studies have demonstrated that TN-hybrid cells could be found in human cancers. However, a prerequisite of this cell fusion search strategy is that such markers are stably expressed by TN-hybrid cells over time. However, cell fusion is a potent inducer of genomic instability, and TN-hybrid cells may lose these cell fusion markers, thereby becoming indistinguishable from nonfused tumor cells. In addition, hybrid cells can evolve from homotypic fusion events between tumor cells or from heterotypic fusion events between tumor cells and normal cells possessing similar markers, which would also be indistinguishable from nonfused tumor cells. Such indistinguishable or invisible hybrid cells will be referred to as dark matter hybrids, which cannot as yet be detected and quantified, but which contribute to tumor growth and progression.

Citing Articles

Cell fusion as a driver of metastasis: re-evaluating an old hypothesis in the age of cancer heterogeneity.

Lopez-Collazo E, Hurtado-Navarro L Front Immunol. 2025; 16:1524781.

PMID: 39967663 PMC: 11832717. DOI: 10.3389/fimmu.2025.1524781.

Toto-Cell: A new software to analyze cellular events during video-microscopy.

Renaud L, Renaud C, Delepoulle S, Asselin E PLoS One. 2024; 19(6):e0302042.

PMID: 38905217 PMC: 11192387. DOI: 10.1371/journal.pone.0302042.

How Much Do You Fuse? A Comparison of Cell Fusion Assays in a Breast Cancer Model.

Sieler M, Dornen J, Dittmar T Int J Mol Sci. 2024; 25(11).

PMID: 38891857 PMC: 11172233. DOI: 10.3390/ijms25115668.

scRNAseq and High-Throughput Spatial Analysis of Tumor and Normal Microenvironment in Solid Tumors Reveal a Possible Origin of Circulating Tumor Hybrid Cells.

Ali A, Raza A Cancers (Basel). 2024; 16(7).

PMID: 38611120 PMC: 11010995. DOI: 10.3390/cancers16071444.

Spontaneous Fusion with Transformed Mesenchymal Stromal Cells Results in Complete Heterogeneity in Prostate Cancer Cells.

Wang R, Hu P, Wang F, Lyu J, Ou Y, Edderkaoui M Cancers (Basel). 2024; 16(5).

PMID: 38473313 PMC: 10931070. DOI: 10.3390/cancers16050951.

References

Melzer C, von der Ohe J, Hass R . MSC stimulate ovarian tumor growth during intercellular communication but reduce tumorigenicity after fusion with ovarian cancer cells. Cell Commun Signal. 2018; 16(1):67. PMC: 6186086. DOI: 10.1186/s12964-018-0279-1. View

Dittmar T, Nagler C, Schwitalla S, Reith G, Niggemann B, Zanker K . Recurrence cancer stem cells--made by cell fusion?. Med Hypotheses. 2009; 73(4):542-7. DOI: 10.1016/j.mehy.2009.05.044. View

LaBerge G, Duvall E, Grasmick Z, Haedicke K, Pawelek J . A Melanoma Lymph Node Metastasis with a Donor-Patient Hybrid Genome following Bone Marrow Transplantation: A Second Case of Leucocyte-Tumor Cell Hybridization in Cancer Metastasis. PLoS One. 2017; 12(2):e0168581. PMC: 5287451. DOI: 10.1371/journal.pone.0168581. View

Cirello V, Fugazzola L . Novel insights into the link between fetal cell microchimerism and maternal cancers. J Cancer Res Clin Oncol. 2016; 142(8):1697-704. DOI: 10.1007/s00432-015-2110-3. View

Kaur E, Rajendra J, Jadhav S, Shridhar E, Goda J, Moiyadi A . Radiation-induced homotypic cell fusions of innately resistant glioblastoma cells mediate their sustained survival and recurrence. Carcinogenesis. 2015; 36(6):685-95. DOI: 10.1093/carcin/bgv050. View

Dittmar T, Zanker K . Cell fusion in health and disease. Volume II: cell fusion in disease. Introduction. Adv Exp Med Biol. 2011; 714:1-3. DOI: 10.1007/978-94-007-0782-5_1. View

Dittmar T, Zanker K . Tissue Regeneration in the Chronically Inflamed Tumor Environment: Implications for Cell Fusion Driven Tumor Progression and Therapy Resistant Tumor Hybrid Cells. Int J Mol Sci. 2015; 16(12):30362-81. PMC: 4691180. DOI: 10.3390/ijms161226240. View

Solomon D, Kim T, Diaz-Martinez L, Fair J, Elkahloun A, Harris B . Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science. 2011; 333(6045):1039-43. PMC: 3374335. DOI: 10.1126/science.1203619. View

Godinho S, Kwon M, Pellman D . Centrosomes and cancer: how cancer cells divide with too many centrosomes. Cancer Metastasis Rev. 2009; 28(1-2):85-98. DOI: 10.1007/s10555-008-9163-6. View

10.

Wang R, Sun X, Wang C, Hu P, Chu C, Liu S . Spontaneous cancer-stromal cell fusion as a mechanism of prostate cancer androgen-independent progression. PLoS One. 2012; 7(8):e42653. PMC: 3411834. DOI: 10.1371/journal.pone.0042653. View

11.

Zhou X, Merchak K, Lee W, Grande J, Cascalho M, Platt J . Cell Fusion Connects Oncogenesis with Tumor Evolution. Am J Pathol. 2015; 185(7):2049-60. PMC: 4483464. DOI: 10.1016/j.ajpath.2015.03.014. View

12.

Hanks S, Coleman K, Reid S, Plaja A, Firth H, Fitzpatrick D . Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat Genet. 2004; 36(11):1159-61. DOI: 10.1038/ng1449. View

13.

Kurgyis Z, Kemeny L, Buknicz T, Groma G, Olah J, Jakab A . Melanoma-Derived BRAF(V600E) Mutation in Peritumoral Stromal Cells: Implications for in Vivo Cell Fusion. Int J Mol Sci. 2016; 17(6). PMC: 4926511. DOI: 10.3390/ijms17060980. View

14.

Johansson C, Youssef S, Koleckar K, Holbrook C, Doyonnas R, Corbel S . Extensive fusion of haematopoietic cells with Purkinje neurons in response to chronic inflammation. Nat Cell Biol. 2008; 10(5):575-83. PMC: 4230437. DOI: 10.1038/ncb1720. View

15.

Chakraborty A, Lazova R, Davies S, Backvall H, Ponten F, Brash D . Donor DNA in a renal cell carcinoma metastasis from a bone marrow transplant recipient. Bone Marrow Transplant. 2004; 34(2):183-6. DOI: 10.1038/sj.bmt.1704547. View

16.

Grigsby R, FAIRBAIRN D, ONeill K . Differential DNA damage detected in hybridomas. Hybridoma. 1993; 12(6):755-61. DOI: 10.1089/hyb.1993.12.755. View

17.

Dittmar T, Nagler C, Niggemann B, Zanker K . The dark side of stem cells: triggering cancer progression by cell fusion. Curr Mol Med. 2013; 13(5):735-50. DOI: 10.2174/1566524011313050005. View

18.

Fan H, Lu S . Fusion of human bone hemopoietic stem cell with esophageal carcinoma cells didn't generate esophageal cancer stem cell. Neoplasma. 2014; 61(5):540-5. DOI: 10.4149/neo_2014_066. View

19.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

20.

Davies P, Powell A, Swain J, Wong M . Inflammation and proliferation act together to mediate intestinal cell fusion. PLoS One. 2009; 4(8):e6530. PMC: 2716548. DOI: 10.1371/journal.pone.0006530. View